Studies on Increased Heparin Resistance Measured by the Plasma Heparin Thrombin Time^[*]

Summary

Increased heparin resistance was found to remain unchanged in BaSO₄-adsorbed plasma, but disappeared following adsorption with large quantities of Al(OH)₃. The factor V content in the plasma could be considerably reduced without any alteration in the heparin resistance. Antihaemophilic globulin exerted no influence upon the heparin thrombin time. Tissue thromboplastin in quantities sufficient to accelerate the clotting of recalcified plasma considerably, did not affect the heparin thrombin time. Plasma thromboplastin had no antiheparin effect. Increased heparin resistance was — although usually less marked — still demonstrable in most cases in plasma defibrinated with thrombin from patients with a greatly shortened heparin thrombin time, but not in cases of less pronounced shortening. Fibrinogen prepared by the freeze-thaw technique from normal plasma and patient plasma showed no difference in reactivity to heparin and thrombin. In experiments on plasma mixtures, a shortening of the heparin thrombin time was still demonstrable at the ratio 9 parts of normal plasma to 1 part of plasma from patients with greatly increased heparin resistance. The antithrombin content of plasma was not reduced in increased heparin resistance.

^* Aided by grants from Arvid Nilsson’s Foundation, Copenhagen, Denmark.

• References

• (1) Astrup T, Darling S. Investigations on fibrinogen. Acta phys. scand. 4: 45 1942;
• (2) Astrup T, Darling S. Measurement and properties of antithrombin. Acta physiol. scand. 4: 293 1942;
• (3) Astrup T, Claassen M. The fibrinolytic and the thromboplastic activities of the arterial wall. 6th European Congress of Haematology. Abstract 101 Copenhagen: 1957
• (4) Biggs R, Douglas A. S. The thromboplastin generation test. J. clin. Path. 6: 23 1953;
• (5) Biggs R, Douglas A. S, Macfarlane R. G. The action of thromboplastic substances. J. Physiol. 122: 554 1953;
• (6) Biggs R, Macfarlane R. G. Human blood coagulation and its disorders. Blackwell Scientific Publications; Oxford: 1957
• (7) Brambel C. E, Corwin A. H, Capone V. A. Mechanism of action of heparin as an etiological basis for homeostasis (hemorrhage and thrombosis). Amer. J. med. Sei. 230: 276 1955;
• (8) Christensen L. Korsgaard. A method for determination of fibrin in plasma. Scand. J. clin. Lab. Invest. 7: 246 1955;
• (9) Fischer A. Die Bindung von Heparin an Eiweiß. Biochem. Z. 278: 133 1935;
• (10) Fischer A, Astrup T. Stöchiometrische Bindungsverhältnisse zwischen Heparin und Gerinnungsstoff. Biochem. Z. 278: 326 1935;
• (11) Gormsen J. Coagulation problems in acute coronary thrombosis. (in Danish with an English summary). Thesis. Copenhagen: 1957
• (12) Gormsen J. A technique for the heparin tolerance test. Brit. J. Haemat. 5: 257 1959;
• (13) Hjort P. F. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scand. J. clin. Lab. Invest.. 9. suppl. 27 1957
• (14) Holger-Madsen T. The plasma heparin thrombin time. Acta haemat. (Basel) 21: 301 1959;
• (15) Holger-Madsen T, Schioler M. Increased heparin resistance after operation, measured by the plasma heparin thrombin time. Acta chir. scand. 118: 257 1960;
• (16) Holger-Madsen T. Heparin resistance in acute coronary occlusion, measured by the plasma heparin thrombin time. Acta haemat. (Basel) 23: 195 1960;
• (17) Koller F. Über die klinische Bedeutung der Blutgerinnungsstörungen. Schweiz. med. Wschr. 75: 290 1945;
• (18) Koller F. Die Prophylaxe und Therapie der Thrombose mit Antikoagulantien. Helv. med. Acta 16: 184 1949;
• (19) Owren P. A. A quantitative one-stage method for the assay of prothrombin. Scand. J. clin. Lab. Invest. 1: 81 1949;
• (20) Poller L. Factor VII and heparin in thrombosis. J. clin. Path. 12: 331 1959;
• (21) Quick A. J. On the action of heparin and its relation to thromboplastin. Amer. J. Physiol. 115: 317 1936;
• (22) Quick A. J. The physiological protective mechanism against intravascular clotting. Angiology 10: 386 1959;
• (23) Soulier J. P, le Bolloch A. G. Le test de tolerance à l’héparine “in vitro”. Rev. Hémat. 5: 148 1950;
• (24) Stormorken H. Reactivity of stored plasma to thrombin, with reference to the fibrinogen conversion accelerator and heparinoid activity. Brit. J. Haemat. 3: 299 1957;
• (25) Volkert M, Piper J. Heparin content of the blood in clinical thrombosis. Acta chir. scand. 89: 417 1944;
• (26) Ware A. G, Guest M. M, Seegers W. H. Fibrinogen: With special reference to its preparation and certain properties of the product. Arch. Biochem. 13: 231 1947;
• (27) Waugh T. R, Ruddick D. W. Studies on increased coagulability of the blood. Canad. med. Ass. J. 51: 11 1944;